Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kendra T. Talbott"'
Autor:
David B. Weiner, Stephan J. Wu, Gary P. Kobinger, Jenna Aviles, Devon J. Shedlock, Gary Wong, Daniel O. Villarreal, Devin J.F. Myles, Jian Yan, Maria A. Croyle, Kendra T. Talbott
Publikováno v:
Molecular Therapy. 21(7):1432-1444
Marburg and Ebola hemorrhagic fevers have been described as the most virulent viral diseases known to man due to associative lethality rates of up to 90%. Death can occur within days to weeks of exposure and there is currently no licensed vaccine or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d8f8b34e38175366d158771fedf055
Publikováno v:
Expert Review of Vaccines. 12:537-554
The human body has developed an elaborate defense system against microbial pathogens and foreign antigens. However, particular microbes have evolved sophisticated mechanisms to evade immune surveillance, allowing persistence within the human host. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba8b3e94b0a6b3d9096565a6c5242c5
https://doi.org/10.1586/erv.13.33
https://doi.org/10.1586/erv.13.33
Autor:
Niranjan Y. Sardesai, Jean D. Boyer, Karuppiah Muthumani, Sita Awasthi, Kendra T. Talbott, Devon J. Shedlock, Christine Wilson, David B. Weiner, Stephan J. Wu
Publikováno v:
Human Vaccines & Immunotherapeutics. 8:1668-1681
There is no licensed vaccine or cure for human cytomegalovirus (CMV), a ubiquitous β-herpesvirus infecting 60–95% of adults worldwide. Infection can cause congenital abnormalities, result in severe disease in immunocompromised patients, and is a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc7fe21330a90cbe9f87b2781af1822
https://doi.org/10.4161/hv.22447
https://doi.org/10.4161/hv.22447
Autor:
Niranjan Y. Sardesai, Colleen E. Lucke, Neil J. Cisper, Amir S. Khan, Lindsey Philipson-Weiner, Kendra T. Talbott, Bernadette Ferraro, David B. Weiner
Publikováno v:
Human Vaccines. 7:120-127
Prostate cancer (PCa) remains a significant public health problem. Current treatment modalities for PCa can be useful, but may be accompanied by deleterious side effects and often do not confer long-term control. Accordingly, additional modalities, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4443a9d6ebb64629555f1fd938da9930
https://doi.org/10.4161/hv.7.0.14574
https://doi.org/10.4161/hv.7.0.14574
IL-28B/IFN-λ3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques
Autor:
Matthew P. Morrow, Mark G. Lewis, David B. Weiner, Roberta Toporovski, Amir S. Khan, Jian Yan, Niranjan Y. Sardesai, Devon J. Shedlock, Panyupa Pankhong, Kendra T. Talbott
Publikováno v:
Molecular Therapy. 18:1714-1723
Type III/lambda interferons (IFNs) were discovered less than a decade ago and are still in the process of being characterized. Although previous studies have focused on the function of IFN-lambda 3 (also known as interleukin (IL)-28B) in a small anim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e056322795dc962d291157a603378e
https://doi.org/10.1038/mt.2010.118
https://doi.org/10.1038/mt.2010.118
Autor:
David B. Weiner, Nyamekye Obeng-Adjei, A. J. Birkett, W. Cabrera, Amir S. Khan, Matthrew P. Morrow, Devon J. Shedlock, Ami Shah Brown, A. K. K. Kayatani, A. Balakrishnan, N. Richie, R. Shiver, Jian Yan, Bernadette Ferraro, Devin J.F. Myles, Neil J. Cisper, Niranjan Y. Sardesai, Kendra T. Talbott, M. Yang, U. Wille-Reece, Natalie A. Hutnick
A vaccine candidate that elicits humoral and cellular responses to multiple sporozoite and liver-stage antigens may be able to confer protection against Plasmodium falciparum malaria; however, a technology for formulating and delivering such a vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfe604d8efa4cda4ff9b9054cfeaba3
https://europepmc.org/articles/PMC3811783/
https://europepmc.org/articles/PMC3811783/
Autor:
Niranjan Y. Sardesai, Matthew P. Morrow, Christina Cress, David B. Weiner, Steven Tuyishme, Amir S. Khan, Karuppiah Muthumani, Omkar U. Kawalekar, Devon J. Shedlock, Bernadette Ferraro, Karthik Mallilankaraman, Kendra T. Talbott, Neil J. Cisper, Hao Shen, Stephan J. Wu
Protection against infection is the hallmark of immunity and the basis of effective vaccination. For a variety of reasons there is a great demand to develop new, safer and more effective vaccine platforms. In this regard, while ‘first-generation’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8578c20a53cd1b923755e01b56bcb05
https://europepmc.org/articles/PMC3167034/
https://europepmc.org/articles/PMC3167034/
Autor:
Matthew P. Morrow, David B. Weiner, Devon J. Shedlock, David A. Hokey, Karuppiah Muthumani, Kendra T. Talbott, Bernadette Ferraro
Publikováno v:
Cytometry Part A.
The capacity for robust proliferation upon re-infection is a hallmark of adaptive immunity and the basis of vaccination. A widely used animal model for the study of human disease is the rhesus macaque (RM), where capacity for proliferation can be ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f41ebd7259c6decd3159126a91e808c6
https://doi.org/10.1002/cyto.a.20857
https://doi.org/10.1002/cyto.a.20857